The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

NCT06069180 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: Busulfan
DRUG: Flu/Cy/ATG or Cy/ATG

Sponsor

Peking University People's Hospital